Clinical Trial Update: AB-1005 Long-Term Follow-up Study

View source ↗

Summary

AskBio's AB-1005 long-term follow-up study is ongoing, enrolling by invitation for Parkinson's disease and related disorders including multiple system atrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy
• Parkinson Disease

Drugs mentioned

• AB-1005

Snippet

Sponsor: AskBio Inc | Conditions: Parkinson's Disease, Multiple System Atrophy, Parkinson Variant | Status: ENROLLING_BY_INVITATION